Transcriptional repression of the anti-apoptotic survivin gene by wild type p53

被引:669
作者
Hoffman, WH
Biade, S
Zilfou, JT
Chen, JD
Murphy, M
机构
[1] Fox Chase Canc Ctr, Dept Pharmacol, Philadelphia, PA 19111 USA
[2] Univ S Florida, H Lee Moffitt Canc Ctr, Mol Oncol Program, Tampa, FL 33612 USA
关键词
D O I
10.1074/jbc.M106643200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Survivin is a member of the inhibitor of apoptosis family. This apoptosis inhibitor also has an evolutionarily conserved role as a mitotic spindle checkpoint protein. Previous studies on p53-repressed genes have implicated several genes involved in the G(2)/M transition of the cell cycle as targets of negative regulation by p53. However, few targets of p53 repression that are antiapoptotic have been identified. This study identifies the anti-apoptotic survivin gene as a p53-repressed gene. Notably, Survivin repression by p53 is shown to be distinct from p53-dependent growth arrest. Chromatin immunoprecipitations indicate that p53 binds the survivin promoter in vivo; immunobinding studies indicate that this site overlaps with a binding site for E2F transcription factors and is subtly distinct from a canonical p53-transactivating element. The survivin-binding site contains a 3-nucleotide spacer between the two decamer "half-sites" of the p53 consensus element; deletion of this spacer is sufficient to convert the survivin site into a transactivating element. Finally, we show that overexpression of Survivin in cells sensitive to p53-dependent cell death markedly inhibits apoptosis induced by ultraviolet light. The identification of survivin as a p53 repressed gene should aid in the elucidation of the contribution of transcriptional repression to p53-dependent apoptosis.
引用
收藏
页码:3247 / 3257
页数:11
相关论文
共 54 条
[1]   Anti-apoptosis gene, survivin, and prognosis of neuroblastoma [J].
Adida, C ;
Berrebi, D ;
Peuchmaur, M ;
Reyes-Mugica, M ;
Altieri, DC .
LANCET, 1998, 351 (9106) :882-883
[2]  
Adida C, 1998, AM J PATHOL, V152, P43
[3]   Down-regulation of the stathmin/Op18 and FKBP25 genes following p53 induction [J].
Ahn, J ;
Murphy, M ;
Kratowicz, S ;
Wang, A ;
Levine, AJ ;
George, DL .
ONCOGENE, 1999, 18 (43) :5954-5958
[4]   A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma [J].
Ambrosini, G ;
Adida, C ;
Altieri, DC .
NATURE MEDICINE, 1997, 3 (08) :917-921
[5]   Induction of apoptosis and inhibition of cell proliferation by survivin gene targeting [J].
Ambrosini, G ;
Adida, C ;
Sirugo, G ;
Altieri, DC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (18) :11177-11182
[6]   Repression of CDK1 and other genes with CDE and CHR promoter elements during DNA damage-induced G2/M arrest in human cells [J].
Badie, C ;
Itzhaki, JE ;
Sullivan, MJ ;
Carpenter, AJ ;
Porter, ACG .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (07) :2358-2366
[7]  
Choki I, 1998, ANTICANCER RES, V18, P4213
[8]   The gene encoding p202, an interferon-inducible negative regulator of the p53 turner suppressor, is a target of p53-mediated transcriptional repression [J].
D'Souza, S ;
Xin, H ;
Walter, S ;
Choubey, D .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (01) :298-305
[9]   MICE LACKING P21(C/P1/WAF1) UNDERGO NORMAL DEVELOPMENT, BUT ARE DEFECTIVE IN G1 CHECKPOINT CONTROL [J].
DENG, CX ;
ZHANG, PM ;
HARPER, JW ;
ELLEDGE, SJ ;
LEDER, P .
CELL, 1995, 82 (04) :675-684
[10]   IAP family proteins - suppressors of apoptosis [J].
Deveraux, QL ;
Reed, TC .
GENES & DEVELOPMENT, 1999, 13 (03) :239-252